Studying 113 recalls from 2005-2009 that could cause serious health problems or death, researchers found 71 percent were cleared through the less rigorous process and an additional 7 percent were exempted from any FDA regulation.
Researchers also found that 31 percent of the high-risk device recalls were in cardiology and 51 percent were in one of five other categories: general hospital, anesthesiology, clinical chemistry, neurology and ophthalmology.
Related Articles in Medical Device Recalls:
American Regent Initiates Recall of Vasopressin Injection Lots
Infusion Pumps Plagued by Multiple FDA Recalls
GAO Report: FDA Should Tighten Oversight of Device Recalls
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.